FAKTOR OPTIONSSCHEIN - SMITH & NEPHEW | Real-time BOERSE MUENCHEN 14:26:07 2024-06-05 EDT | ||
| 14.46 EUR | -6.53% |
|
| Current month | -7.13% | ||
| 1 month | -5.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 24-06-05 | 14.46 | -6.53% |
| 24-06-04 | 15.47 | -1.96% |
| 24-06-03 | 15.78 | +1.35% |
| 24-05-31 | 15.57 | -0.26% |
| 24-05-30 | 15.61 | -2.38% |
Real-time BOERSE MUENCHEN
Last update June 05, 2024 at 02:26 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Goldman Sachs |
| WKN | GG33J6 |
| ISIN | DE000GG33J65 |
| Date issued | 2024-02-12 |
| Strike | 1,493 p |
| Maturity | Unlimited |
| Parity | 0.38 : 1 |
| Emission price | 13.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.96 € |
|---|---|
| Lowest since issue | 12.24 € |
| Spread | 0.5 € |
| Spread % | 3.40% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.13
USD
Average target price
16.45
USD
Spread / Average Target
+25.34%
- Stock Market
- Certificates
- Certificat
